Home NDC 83723-010 Sofdra
Product NDC 83723-010
11-digit product format 837230010
Labeler code 83723
Product ID 83723-010_3f660131-556e-fa6f-e063-6294a90a3dec
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name sofpironium bromide
Dosage form GEL
Route TOPICAL
Labeler Botanix SB Inc.
Application NDA217347
Marketing category NDA
Marketing start 2024-08-06
Substance SOFPIRONIUM BROMIDE
Active strength 87 mg/.67mL
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217347-001 SOFDRA SOFPIRONIUM BROMIDE EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18
Orange Book patents# Current patent rows page 1 of 1 · 21 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217347-001 8628759 2026-11-13 U-2398 2024-09-26 N217347-001 8147809 2027-03-26 Drug substance, Drug product 2024-09-26 N217347-001 10383846 2034-03-14 U-2398 2024-09-26 N217347-001 9220707 2034-03-14 U-2398 2024-09-26 N217347-001 9492429 2034-03-14 U-2398 Drug product 2024-09-26 N217347-001 9895350 2034-03-14 U-2398 2024-09-26 N217347-001 10947192 2034-05-22 U-2398 2024-09-26 N217347-001 10952990 2034-05-22 U-2398 2024-09-26 N217347-001 10959983 2034-05-22 U-2398 2024-09-26 N217347-001 10961191 2034-05-22 U-2398 2024-09-26 N217347-001 11026919 2034-05-22 U-2398 Drug product 2024-09-26 N217347-001 11034652 2034-05-22 U-2398 Drug product 2024-09-26 N217347-001 11052067 2034-05-22 U-2398 Drug product 2024-09-26 N217347-001 11084788 2034-05-22 U-2398 Drug product 2024-09-26 N217347-001 12156865 2034-05-22 U-2398 Drug product 2025-06-10 N217347-001 12357609 2034-05-22 U-2398 Drug product 2025-08-14 N217347-001 12398102 2034-05-22 U-2398 Drug product 2025-09-23 N217347-001 11123325 2037-07-20 U-2398 Drug product 2024-09-26 N217347-001 11566000 2040-05-22 Drug substance, Drug product 2024-09-26 N217347-001 11584715 2040-05-22 Drug substance, Drug product 2024-09-26 N217347-001 12703682 2040-05-22 Drug substance, Drug product 2026-09-08
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217347-001 NCE 2029-06-20
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 84e616aacf4f…2026-08-18 06:07:40 2026-07 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 301d65b070ca…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217347-001 SOFDRA EQ 12.45% BASE (EQ 72MG BASE/ACTUATION) GEL, METERED / TOPICAL RLD, RS 2024-06-18 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 6 · 207 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N217347-001 8628759 2026-11-13 U-2398 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 8147809 2027-03-26 Drug substance, Drug product 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 10383846 2034-03-14 U-2398 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 9220707 2034-03-14 U-2398 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 9492429 2034-03-14 U-2398 Drug product 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 9895350 2034-03-14 U-2398 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 10947192 2034-05-22 U-2398 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 10952990 2034-05-22 U-2398 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 10959983 2034-05-22 U-2398 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 10961191 2034-05-22 U-2398 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 11026919 2034-05-22 U-2398 Drug product 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 11034652 2034-05-22 U-2398 Drug product 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 11052067 2034-05-22 U-2398 Drug product 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 11084788 2034-05-22 U-2398 Drug product 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 12156865 2034-05-22 U-2398 Drug product 2025-06-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 12357609 2034-05-22 U-2398 Drug product 2025-08-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 12398102 2034-05-22 U-2398 Drug product 2025-09-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 11123325 2037-07-20 U-2398 Drug product 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 11566000 2040-05-22 Drug substance, Drug product 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 11584715 2040-05-22 Drug substance, Drug product 2024-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217347-001 12703682 2040-05-22 Drug substance, Drug product 2026-09-08 84e616aacf4f…2026-08-18 06:07:40 2026-07 N217347-001 8628759 2026-11-13 U-2398 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 8147809 2027-03-26 Drug substance, Drug product 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 10383846 2034-03-14 U-2398 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 9220707 2034-03-14 U-2398 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 9492429 2034-03-14 U-2398 Drug product 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 9895350 2034-03-14 U-2398 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 10947192 2034-05-22 U-2398 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 10952990 2034-05-22 U-2398 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 10959983 2034-05-22 U-2398 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 10961191 2034-05-22 U-2398 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 11026919 2034-05-22 U-2398 Drug product 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 11034652 2034-05-22 U-2398 Drug product 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 11052067 2034-05-22 U-2398 Drug product 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 11084788 2034-05-22 U-2398 Drug product 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 12156865 2034-05-22 U-2398 Drug product 2025-06-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 12357609 2034-05-22 U-2398 Drug product 2025-08-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 12398102 2034-05-22 U-2398 Drug product 2025-09-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 11123325 2037-07-20 U-2398 Drug product 2024-09-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217347-001 11566000 2040-05-22 Drug substance, Drug product 2024-09-26 caaa826d4ba7…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Sofdra
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SOFPIRONIUM BROMIDE 87 mg/.67mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 7B2Y1932XU Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2689326 Internal RxNorm lookup 2689332 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 83723-010-50 Sofdra 1 in 1 CARTON GEL 1 6 83723-010-50 Sofdra 50 mL in 1 BOTTLE GEL 50 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 83723-010 SOFDRA (SOFPIRONIUM BROMIDE) GEL [BOTANIX SB INC.] 5 Current NDC, 2 package rows 20240828_78f86f4f-658c-468b-bd54-49182ddcc7ac.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 83723-010-50 83723001050 1 BOTTLE in 1 CARTON (83723-010-50) / 50 mL in 1 BOTTLE 1 bottle 2024-08-06 No No Current